Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Syngenta increases Q3 sales by 27%

10/28/2021 | 02:38am EST
FILE PHOTO: Logo is seen at the headquarters of agricultural chemical maker Syngenta in Basel

ZURICH (Reuters) - Syngenta Group, the Swiss agrochemicals group which aims to raise $10 billion from an initial public offering this year, increased its third quarter sales by 27%, the Chinese-owned company said on Thursday.

It increased its sales to $6.5 billion from $5.1 billion a year earlier as it cashed in on higher grain prices while it tackled what it called a worsening supply chain situation.

Syngenta said it was "actively managing" its supply chain to offset global market constraints, a situation made worse in China by energy shortages hitting pesticide and crop nutrition manufacturing during the third quarter.

Procurement, logistics and other operating cost increases were partially offset by higher selling prices across all businesses, Syngenta added.

Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 13% to $800 million, the company said.

Syngenta was seeing particularly strong demand for products which help farmers overcome extreme weather conditions such as a spray made from seaweed which helps grape vines deal with temperature extremes.

Syngenta, which competes with Germany's Bayer and U.S. agrochemicals company Corteva, was bought by state-owned ChemChinafor $43 billion in 2017, and is now poised for a flotation.

The Shanghai stock exchange this month resumed a review of the flotation, after the process was temporarily suspended when the company needed to provide updated financial reports.

(Reporting by John Revill)


ę Reuters 2021
All news about BAYER AG
12/06Recursion Pharmaceuticals to Expand Fibrosis Collaboration With Bayer to Include Infere..
MT
12/05Beijing biotech firm banks on GM corn in race to be China's Monsanto
RE
12/03BAYER AG : Buy rating from UBS
MD
12/03Bayer's Nubeqa Notches Clinical Trial Win in New Prostate Cancer Indication
MT
12/03Bayer's Nubeqa drug improves survival in prostate cancer trial
RE
12/03Bayer Prostate Cancer Combo Found to Extend Lives in Late-Stage Study
MT
12/03BAYER : Phase III trial with Nubeqa™ (darolutamide) in combination with docetaxel an..
PU
12/01Bayer To Make $113 Million Investment To Drive Sustainable Use Of Products
MT
12/01Bayer Invests ?100 Million in Sustainable Health Products to Advance Company's 2030 Sus..
CI
11/30Elanco Animal Health to cut 380 jobs globally
RE
More news
Analyst Recommendations on BAYER AG
More recommendations
Financials
Sales 2021 42 989 M 48 375 M 48 375 M
Net income 2021 412 M 464 M 464 M
Net Debt 2021 38 333 M 43 136 M 43 136 M
P/E ratio 2021 70,9x
Yield 2021 4,59%
Capitalization 43 801 M 49 398 M 49 290 M
EV / Sales 2021 1,91x
EV / Sales 2022 1,80x
Nbr of Employees 99 814
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | MarketScreener
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 44,59 €
Average target price 62,21 €
Spread / Average Target 39,5%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG-7.41%49 398
JOHNSON & JOHNSON3.53%428 955
ROCHE HOLDING AG17.23%322 390
PFIZER, INC.44.09%288 950
NOVO NORDISK A/S65.08%245 091
ELI LILLY AND COMPANY45.45%223 321